Pharmaceuticals Mexico

Mexico Essential Tremor Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Mexico Essential Tremor Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Severity, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Mexico · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.9 Mn Placeholder estimate
Estimate 2025 $10.7 Mn 1.5% of the global market
Projected 2034 $22.6 Mn 110.1% Adds $11.8 Mn over 9 forecast years
CAGR 2025–2034 8.6% Faster than 53% of 180 Pharmaceuticals markets here
Key players 5
  • Mexico is 1.53% of the global market.
  • In Latin America, the largest is Brazil at $18.3 Mn.
  • Fastest growing: Brazil at 8.9% a year.
  • Mexico ranks 3rd of 3 by size in Latin America.

Market size projection

Mexico

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$11.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Essential Tremor Treatment Market market size by year, Mexico
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.9 Mn — —
2025 (base) $10.7 Mn +$0.8 Mn —
2026 (forecast) $11.7 Mn +$0.9 Mn +8.6%
2027 (forecast) $12.7 Mn +$1.0 Mn +17.9%
2028 (forecast) $13.7 Mn +$1.1 Mn +28.1%
2029 (forecast) $14.9 Mn +$1.2 Mn +39.1%
2030 (forecast) $16.2 Mn +$1.3 Mn +51.1%
2031 (forecast) $17.6 Mn +$1.4 Mn +64.1%
2032 (forecast) $19.1 Mn +$1.5 Mn +78.2%
2033 (forecast) $20.8 Mn +$1.6 Mn +93.5%
2034 (forecast) $22.6 Mn +$1.8 Mn +110.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $699.8 Mn
  2. North America $362.8 Mn
  3. US $287.1 Mn
  4. APAC $148.3 Mn
  5. Europe $136.5 Mn
  6. China $62.8 Mn
  7. Canada $51.8 Mn
  8. Japan $47.0 Mn
  9. Middle East $31.7 Mn
  10. Latin America $30.3 Mn
  11. Germany $22.0 Mn
  12. Brazil $18.3 Mn
  13. France $16.1 Mn
  14. Italy $16.2 Mn
  15. UK $15.7 Mn
  16. Ecuador $14.3 Mn
  17. Spain $13.6 Mn
  18. Africa $11.9 Mn
  19. India $11.9 Mn
  20. Mexico (this report) $10.7 Mn
  21. Saudi Arabia $10.7 Mn
  22. New Zealand $7.7 Mn
  23. Australia $7.7 Mn
  24. Russia $7.1 Mn
  25. South Africa $4.9 Mn
  26. UAE $3.8 Mn
  27. Egypt $1.9 Mn
  28. Philippines $1.5 Mn
  29. Malaysia $1.2 Mn
  30. Hong Kong $1.1 Mn
  31. Singapore $0.8 Mn
  32. Thailand $0.8 Mn
  33. Kenya $0.5 Mn

Report snapshot

Mexico Essential Tremor Treatment Market Analysis at a glance
Market size, 2025$10.7 Mn placeholder estimate
Forecast, 2034$22.6 Mn placeholder estimate
Growth (CAGR), 2025–20348.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, severity and end user (see all)
Key playersInsightec, Medtronic, Cala Health, Abbott Laboratories, Sage Therapeutics (see all)
Regulator in MexicoCOFEPRISSource: COFEPRIS. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Mexico Essential Tremor Treatment Market Analysis Executive Summary

Essential tremor treatments reduce shaking with medicines, focused ultrasound, brain stimulation and wearable devices.

Key segments of the essential Tremor Treatment market include treatment (Medication, Focused Ultrasound and Deep Brain Stimulation) and severity (Mild, Moderate and Severe).

Bar chart: Mexico Essential Tremor Treatment market size, 2024–2034, placeholder estimates. $9.9 Mn in 2024, $10.7 Mn in 2025 and $22.6 Mn in 2034, 8.6% CAGR.
Mexico Essential Tremor Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Mexico Essential Tremor Treatment Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the essential Tremor Treatment market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the essential Tremor Treatment market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the essential Tremor Treatment market.

Competitive Landscape for Essential Tremor Treatment Market in Mexico

The essential Tremor Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Essential Tremor Treatment Market in Mexico

Essential Tremor Treatment in Mexico: rules and payment

Medicines need a sanitary registration from COFEPRIS before sale.⁠[1] Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security.⁠[2]

[1] COFEPRIS. Checked 14 Nov 2026.

[2] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for essential Tremor Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Mexico.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Essential Tremor Treatment right now, from free public sources.

Latest research 945 papers since 2021 (worldwide)

  1. The Modern Utility of Awake Deep Brain Stimulation Surgery. Operative neurosurgery (Hagerstown, Md.), 2026
  2. Gamma knife thalamotomy for essential tremor: can machine learning predict tremor improvement on the day of treatment? Acta neurologica Belgica, 2026
  3. No Additional Benefit of 185 Hz Versus 130 Hz at Equivalent Energy in Deep Brain Stimulation for Tremor: A Randomized Prospective Clinical Trial. Movement disorders clinical practice, 2026
  4. Focused Ultrasound for Movement Disorders: A Bibliometric Analysis Revealing a Critical Research Gap in Mexico. Tremor and other hyperkinetic movements (New York, N.Y.), 2026
  5. Intraoperative asymmetry of thalamic stimulation mapping in Essential Tremor: specificity of first hemisphere implantation and transitory lesioning effect. Frontiers in neurology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Essential Tremor Treatment in context

Mexico compared

  • Health spending per person: 761 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.59 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 8.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Essential Tremor Treatment market in Mexico?
Placeholder estimate: about $10.7 Mn in 2025, rising to about $22.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Essential Tremor Treatment market in Mexico growing?
Placeholder estimate: about 8.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Essential Tremor Treatment market report cover?
The report splits the market by treatment (Medication, Focused Ultrasound, Deep Brain Stimulation, Wearable Neuromodulation), severity (Mild, Moderate, Severe) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Essential Tremor Treatment market?
Key players include Insightec, Medtronic, Cala Health, Abbott Laboratories and Sage Therapeutics.
What is driving the Essential Tremor Treatment market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the essential Tremor Treatment market.
Who regulates Essential Tremor Treatment in Mexico?
Medicines need a sanitary registration from COFEPRIS before sale. Source: COFEPRIS. Checked 14 Nov 2026.
How is healthcare paid for in Mexico?
Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security. Source: Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
How much research is published on Essential Tremor Treatment?
PubMed lists 945 papers on Essential Tremor Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Essential Tremor Treatment in Mexico? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Mexico

See all
Same topic, other categories

Related on brain and nerves

See the topic